Medication Affordability and Patent Integrity Act
On calendar: it can still change before the session ends.
- Stage
- On calendar
- Started in
- Senate
- Sponsors
- 2
- Latest action
- Jul 28, 2026
What it does
The Medication Affordability and Patent Integrity Act would require drug and biological product sponsors to certify to the FDA that information submitted about patentability is consistent with what they provided to the USPTO, and to submit corresponding patent-related information to the USPTO with a certification of completeness and consistency. It applies to new and amended drug and biological product applications, with limited retroactive application for patents issued before enactment. The bill also creates a legal defense against patent infringement claims if a patent owner failed to disclose required information to the FDA or USPTO, and mandates that shared information retain trade…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.